Compile Data Set for Download or QSAR
maximum 50k data
Found 8 of ki for monomerid = 144753
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144753(US8952128, 12 | US8952128, 46)
Affinity DataKi:  0.0600nM ΔG°:  -58.3kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 2(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144753(US8952128, 12 | US8952128, 46)
Affinity DataKi:  0.520nM ΔG°:  -53.0kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 5(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144753(US8952128, 12 | US8952128, 46)
Affinity DataKi:  0.740nM ΔG°:  -52.1kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 4(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144753(US8952128, 12 | US8952128, 46)
Affinity DataKi:  3.20nM ΔG°:  -48.5kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144753(US8952128, 12 | US8952128, 46)
Affinity DataKi:  31.6nMpH: 7.6Assay Description:The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 1(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144753(US8952128, 12 | US8952128, 46)
Affinity DataKi:  98.9nM ΔG°:  -40.0kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetSomatostatin receptor type 3(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144753(US8952128, 12 | US8952128, 46)
Affinity DataKi:  143nM ΔG°:  -39.1kJ/molepH: 7.6 T: 2°CAssay Description:Membranes for in vitro receptor binding assays were obtained by the following procedures. CHO-K1 cells expressing one of the somatostatin receptors w...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetD(2) dopamine receptor(Homo sapiens (Human))
Ipsen Pharma

US Patent
LigandPNGBDBM144753(US8952128, 12 | US8952128, 46)
Affinity DataKi:  255nMpH: 7.6Assay Description:The affinity of a test compound for the human dopamine receptor subtype hDRD2 was determined by radioligand binding assays in CHO-K1 cells stably tra...More data for this Ligand-Target Pair
In DepthDetails US Patent